| Class 2 Device Recall Kit BD Max GC RT PCR Assay | |
Date Initiated by Firm | July 17, 2019 |
Create Date | August 22, 2019 |
Recall Status1 |
Terminated 3 on May 13, 2020 |
Recall Number | Z-2335-2019 |
Recall Event ID |
83406 |
Product Classification |
unknown device name - Product Code N/A
|
Product | Kit BD Max GC RT PCR Assay;
Catalog # 443486 |
Code Information |
Lot # 9092736; UDI (GTIN, DI+PI): (01)00382904434861 (17)200425(10)9092736(30)1; Exp : 4/25/2020 |
Recalling Firm/ Manufacturer |
Becton Dickinson & Co. 7 Loveton Cir Sparks MD 21152-9212
|
For Additional Information Contact | BD Customer/Technical Support 800-638-8663 |
Manufacturer Reason for Recall | The foil bags containing extraction tubes for BD MAX" Reagent products may not been sealed properly. |
FDA Determined Cause 2 | Process control |
Action | 1. Thoroughly inspect all foil bags prior to use. If any of the foil bags in your inventory contain holes, dispose of the product and note the quantity in the attached Customer Response Form in order to request replacement.
2. Even if you do not have inventory of the product listed, complete the attached Customer Response Form and return to the BD contact noted on the form so that BD may acknowledge your receipt of this notification.
3. Share this Advisory Letter with all users of the BD MAX instrument within your facility to ensure awareness.
4. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDAs MedWatch Adverse Event Reporting program.
Web: MedWatch website at www.fda.gov/medwatch
Phone: 1-800-FDA-1088 (1-800-332-1088)
Mail: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787
BD Customer/Technical Support, 800-638-8663
Monday Friday between 7:00am and 7:00pm (EST) in the United States.
For customers outside the US, contact your local BD representative or distributor. |
Quantity in Commerce | 17 units |
Distribution | AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, NH, NJ, NM, NV, NY, OH, OR, PA, PR, RI, SC, TN, TX, VA, WA, WI, WV
Worldwide: Australia, Belgium, Brazil, Canada, Chile, China, Hong Kong, Japan, Korea, Mexico, Singapore, Taiwan |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|